Reply to comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”

Jones, C. M. et al. (2021) Reply to comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”. British Journal of Cancer, 124(3), pp. 679-680. (doi: 10.1038/s41416-020-01133-8) (PMID:33139799) (PMCID:PMC7851158)

[img] Text
291204.pdf - Published Version
Available under License Creative Commons Attribution.

329kB

Abstract

No abstract available.

Item Type:Articles
Additional Information:C.M.J. is supported by a Wellcome Trust Clinical Research Fellowship. K.A. and A.H. acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the Institute of Cancer Research. N.B.J. is supported by a Cancer research UK Clinician Scientist Fellowship (C55370/A25813). M.A.H. is supported by funding from the NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London. S.M. is supported by funding from the NIHR Oxford Biomedical Research Centre.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jamieson, Professor Nigel and Grose, Dr Derek
Authors: Jones, C. M., Radhakrishna, G., Aitken, K., Bridgewater, J., Corrie, P., Eatock, M., Goody, R., Ghaneh, P., Good, J., Grose, D., Holyoake, D., Hunt, A., Jamieson, N. B., Palmer, D. H., Soonawalla, Z., Valle, J. W., Hawkins, M. A., and Mukherjee, S.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:British Journal of Cancer
Publisher:Springer Nature
ISSN:0007-0920
ISSN (Online):1532-1827
Published Online:03 November 2020
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in British Journal of Cancer 124(3):679-680
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
301364COMBINATION THERAPIES TARGETING IMMUNE EVASION IN PANCREATIC CANCERNigel JamiesonCancer Research UK (CRUK)C55370/A25813CS -Translational Research Centre